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Abstract 
Germ cell tumors account for less than 3% of all 
ovarian cancers. These tumors generally appear 
in childhood or in those under 30 years of age. 
Immature ovarian teratoma is the third most 
frequent germ cell tumor after dysgerminoma 
and endodermal sinus tumors. These tumors 
should be distinguished from mature teratomas. 
Discrimination of malignant and benign tumors 
depends on the presence of the 
neuroectodermal components, made up of 
neural and glial cells. Gliomatosis peritonei is 
the intraabdominal and particularly peritoneal 
and omental distribution of the neuroectodermal 
components, observed very rarely with immature 
teratoma. Mature teratoma, on the other hand, is 
even rarer. This report aims to discuss a case of 
immature teratoma completely filling the 
abdomen and concomitant omental distribution 
related gliomatosis peritonei in a 7-year-old 
child.   
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Introduction 
Teratoma tumors of the ovary are the 
most frequently observed germ cell 
tumors. Teratomas originate from all 
three layers of the germ cells and they 
have many subtypes depending on 
mature or immature cell content. The 
common subtypes are mature teratomas 
(MT), immature teratomas (IT) and 
monodermal teratomas. Among these, 
“mature cystic teratoma,” which is also 
known as a dermoid cyst, is the most 
frequently observed, with well-known 
clinical and radiological findings.1,2 Like 
MTs, ITs are lesions that may include all 
three germ cells.3 ITs are different than 
MTs for numerous reasons, including: 
their malignant clinical progressions, 
being early age lesions (commonly the 
first 2 decades), being very rare, being 
unilateral at a high rate, and their 
including histologically immature or 
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embryonic cells.4,5 ITs (mean: 14-25 cm) 
typically reach larger sizes than mature 
cystic teratomas (mean: 7 cm). ITs also 
have a more solid and less cystic 
component, include fat and calcification, 
and can make mass extensions to the 
neighboring tissues with perforation to 
the mass wall. Immature teratomas 
constitute 3% of all ovarian teratomas, 
1% of all ovarian cancers, and 20% of 
malignant germ cell ovarian tumors.3,6 
Mature teratomas are even rarer, and 
the distribution of the neuroepithelial 
tissues—particularly in the immature 
teratomas to the neighboring tissues, 
such as omentum and peritoneum—is 
defined as gliomatosis peritonei.7,8 
Distribution of particularly immature 
neuroepithelial tissues to the 
neighboring tissues in immature 
teratomas is defined as metastasis. This 
metastatic immature neuroepithelial 
distribution has been staged by Norris et 
al. according to the modified Robboy 
and Scully system.7 Extra-ovarian 
distributions are very important with 
regard to prognosis even if they are of 
microscopic size. However, mature 
peritoneal or lymphoid distributions do 
not affect the prognosis negatively and 
these are accepted as benign 
structures, since they include mature 
tissues.8 Immature tissue-related 
malignant transformation is very rare in 
gliomatosis peritonei.9Almost all of the 
dysgerminomas are unilateral ovarian 
tumors if the 15% possibility of bilateral 
appearance is excluded.10,11There is a 
60% chance of early stage diagnosis of 
this group of tumors seen especially in 
children. Protective surgery may be 
planned in patients with progressed 
tumors as well, since the tumor includes 
unilateral ovary.10,11 
In the case of our 7-year-old, a left 
ovarian mass filled the whole abdomen 
including both cystic and solid 
components, we performed a unilateral 
salphingo-opherectomy and 
omentectomy. The pathology report of 
the case included mature glial implants 
within the grade 1 immature teratoma 
and grade 0 omental tissue. The case is 
taken under follow up. 
Case Presentation 
A 7-year-old girl was admitted to our 
clinic with increasing swelling, pain and 
constipation complaints. In the 
examination, a full distended abdominal 
structure with palpable regular and 
unfixed appearance was observed and 
small incisions known as “fisset’’ among 
the population were observed in all 
areas of the abdomen’s anterior wall, 
which are believed to reduce the pain 
(Figure 1).  
 
Figure 1: The view of preoperative 
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abdominal distention and applied 
traditional cuts on the skin called 
‘fisset’. 
Ultrasonography revealed a 20 x 20 cm. 
mass that filled the whole abdomen with 
both solid and cystic components and 
the origin of which could not be defined 
precisely. Anatomic structures of the 
intraabdominal organs could not be 
clearly visualized in the 
ultrasonography(Figure 2-USG).  
 
Figure 2: Abdominal ultrasound 
image of solid and cystic mass 
The abdominal tomographic images 
revealed a 20x18x16 cm sized 
multiloculated mass with malignant and 
ovarian originated appearance, focal 
calcified and fat tissue density, including 
solid and cystic components completely 
filling the abdomen. Anatomic structures 
of the uterus and bilateral ovaries could 
not be clearly visualized (Figure 3). CA-
125 was 1245. Laparotomy was planned 
for the patient with normal laboratory 
findings. The abdominal examination 
revealed a regular contoured, ovarian 
derived benign mass covering the left 
tube and ovary, which was adhered to 
the omentum in its upper side (Figure 
4). 
 
Figure 3: Abdominal tomographic 
image of solid and cystic mass. 
 
Figure 4: Intraoperative appearance 
of mass. 
All organs within the abdomen were 
examined, however, no accompanying 
nodular lesion was detected except for 
the 0.5 cm sized small nodular lesions 
adjacent and adherent to the teratoma 
mass in the omentum. The patient 
underwent left salphingo-opherectomy 
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and omentectomy (Figure 5).  
 
Figure 5: Postoperative view of mass. 
The resected material was sent for 
pathological examination. On gross 
inspection, the pathological  
examination revealed the left ovarian 
mass measured 16 cm. The cut section 
was variegated with solid and cystic 
areas. Hard areas, keratinous debris 
and tufts of hair were also identified. 
Omentum, received as fibrofatty tissue, 
showed fine nodular deposits. 
Microscopically, most areas of the tumor 
were composed of abundant mature 
glial tissue along with skin and adnexal 
structure, glandular elements, mature 
and immature cartilage. Focal areas 
showed primitive neuroepithelium in the 
form of primitive neural tubes and 
rosettes, with rare mitosis (Figure 6). 
The omental implants were composed 
of nodular mature glial tissue (Figure 7). 
A diagnosis of immature teratoma 
(Grade 1) with multiple glial implants in 
omentum (Grade 0) was made. 
Because of a FIGO 1A and grade 1 
differentiation tumor, we decided not to 
give chemotherapy. Sometimes, a 
primary site benign tumor will have a 
metastatic malignant tumor as well as a 
primary malignant tumor may have 
benign metastases.  Additionally, due to 
a concern for future reproductive fertility, 
the decision was made to avoid 
chemotherapy. No pathological finding 
has been detected in the 3-month follow 
up period of the case. 
 
Figure 6:Immature teratoma with 
neuroepithelial rosette formation 
(H&Ex10). 
 
Figure 7: Glial implants in omental 
tissues (H&Ex10). 
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Discussion 
Ovarian masses in children are different 
from those of adults regarding 
histopathological, clinical and prognostic 
properties, and methods of diagnosis 
and treatment.12Ovarian pathologies 
arise in a rather immature base 
physically, hormonally, and 
immunologically. Since the pelvic region 
is superficial and at the same time its 
localization is higher and closer to the 
median plane compared to the adult, 
ovarian pathologies may be diagnosed 
at an earlier stage and easier compared 
to the adults.12,13 
The radiological and laboratory 
examinations of our 7-year-old patient 
with increasing abdominal swelling and 
pain, in addition to nausea and vomiting 
complaints for the last 6 months, 
revealed a mass located close to the 
median plane with both solid and cystic 
components that completely filled the 
abdomen.  
Immature teratomas are lesions that 
may include all three germ cell layers 
like mature teratomas.3Immature 
components are commonly of 
mesenchymal or ectodermal origin. 
Immature neuroectodermal tissue is the 
easiest to distinguish among all other 
tissues. Immature teratomas are 
distinguished from mature teratomas by 
their malignant clinical progression, 
being observed at younger ages 
(commonly in the first 2 decades), being 
more rare and generally unilateral, and 
their including histologically immature or 
embryonic cells.4,5 Patients may 
sometimes admit to clinics with limbic 
encephalitis-like rare paraneoplastic 
syndrome.14 
Immature teratomas constitute 3% of all 
ovarian teratomas, 1% of all ovarian 
cancers, and 20% of malignant germ 
cell ovarian tumors.3,6 
The malignancy risk increases with the 
rate of increase of neuroepithelial 
tissues in immature teratomas. 
Peritoneal gliomatosis is a rare situation 
where mature glial implants are 
detected on the peritoneum, and the 
majority are immature teratoma 
related.15,16Gliomatosis peritonei was 
first defined in 1905 as the co-existence 
of ovary-related teratoma and mature 
glial tissues over the peritoneum and 
omentum.17Approximately 100 cases 
have been reported in literature by this 
time.18 
The presence of mature glial implants 
that accompany immature teratomas 
may be considered as an indicator of 
good prognosis independent from the 
stage of the primary tumor.19The 
formation mechanism of peritoneal or 
omental neuroepithelial implants is not 
yet clearly defined but, two different 
hypothesis have been presented. 
According to the first hypothesis, these 
glial implants are genetically related to 
the primary tumor. It is related to the 
angio cephalic distribution due to the 
capsular defect which arises 
spontaneously or as a result of surgical 
intervention.20According to the second 
hypothesis—which is commonly 
accepted—glial cells are genetically 
independent from the primary tumor and 
arise from normal cells that originate 
from peritoneum or neighboring 
mesenchymal tissues. These cells are 
considered pluripotent mullerian stem 
cells that have introduced the metastatic 
process as a result of a neoplastic 
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stimulation with an unknown origin.21 
Some of the teratoma cases with 
recurrence may be considered related to 
tumor prone syndrome. It has been 
believed that one or more types of 
peritoneal cells facilitate tumor formation 
as a result of exogenous or endogenous 
neoplastic stimuli in tumor prone 
syndrome.22 
Glial fibrillary acidic protein (GFAB) is a 
protein that is produced within 
astrocytes of growth stage, and a dense 
presence in samples obtained from glial 
implants is an indicator of good 
differentiation and maturity.23 
In patients with extra-ovarian 
involvement, the appearance of 
immature teratoma related glial implants 
gains prognostic importance. Mature 
glial cells detected in peritoneum or 
lymph nodes do not affect the prognosis 
negatively. These glial implants 
evaluated as grade 0 include mostly 
mature tissue. Gliomatosis peritonei is 
particularly observed in women with 
immature ovarian teratoma, but may 
very rarely be seen in patients who 
underwent ventriculoperitoneal shunt 
due to hydrocephalus or during 
pregnancy.24,25 
Conservative surgery is generally the 
first-line treatment for immature 
teratomas. Chemotherapy with the 
surgery has been reported to affect the 
prognosis positively.27-29 Chemotherapy 
is not necessary in the presence of 
mature glial implants in immature 
teratomas; however, it has been 
observed that concomitant 
chemotherapy induces the maturation of 
the implants in case these glial implants 
are immature.27The incidence of tumor 
recurrence is increased with factors 
such as tumor stage, capsular 
involvement, vascular invasion, or the 
growth pattern of the tumor in immature 
teratomas.23 
In the literature review of Chou et al., 
the prognosis of 65 cases with 
gliomatosis peritonei has been reported 
good after primary surgical 
treatment.15,26 
In patients with immature teratoma 
including mature glial implants, 
malignant tumor lesions may be 
observed late after the first surgery. 
Therefore, long-term follow-up of these 
patients is recommended.7 
We have followed up on our 7-year-old 
patient with immature teratoma and 
mature gliomatosis peritonei in the 
omental tissue after the primary surgical 
treatment for 3 months without any 
recurrence. 
Conclusion 
Immature teratomas belong to the germ 
cell tumor group, frequently observed in 
childhood. Gliomatosis peritonei is the 
distribution of the neural tissue within 
the teratomas into the abdomen, 
particularly to the omentum and 
peritoneum. It is important that surgeons 
perform a post-operative clinical follow-
up and help with the planning of 
additional treatments. They must also 
be sure to properly sample cases with 
peritoneal or omental gliomatosis of 
prognostic value that accompany 
immature teratomas. 
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